Theseus Pharmaceuticals, Inc.·4

Jan 3, 7:05 AM ET

HAYDEN DONALD J JR 4

4 · Theseus Pharmaceuticals, Inc. · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-29
Transactions
  • Purchase

    Common Stock

    2022-12-29$5.00/sh+100$500100 total
  • Purchase

    Common Stock

    2022-12-30$5.00/sh+9,900$49,48910,000 total
Footnotes (1)
  • [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    tm2233814-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT